John W. Beck, Chief Financial Officer at METABASIS THERAPEUTICS INC (MBRX), sold 8,000 shares at $8.00 ($64K) on 2007-04-09, disclosed to the SEC on 2007-04-10.
Scheduled sale ($64k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.00 | 1,828 | $15K | 22.9% |
| 2 | $8.00 | 6,172 | $49K | 77.1% |
| Total | $8.00 avg | 8,000 | $64K | 100% |
| Filing → |
| RDEA | SELL | 2009-08-17 | $50K | — | Filing → |
| RDEA | SELL | 2009-05-21 | $75K | — | Filing → |
| MBRX | SELL | 2007-06-21 | $27K | — | Filing → |